Company Filing History:
2 out of 3 
1 out of 10 
1 out of 1 Years Active: 2019-2024
Title: Sònia Guedan Carrió: Innovator in Oncolytic Adenoviruses
Introduction
Sònia Guedan Carrió is a prominent inventor based in Manresa, Spain. He has made significant contributions to the field of cancer treatment through his innovative work on oncolytic adenoviruses. With a total of two patents to his name, Guedan Carrió is recognized for his groundbreaking research aimed at improving cancer therapies.
Latest Patents
Guedan Carrió's latest patents focus on the development of oncolytic adenoviruses for treating cancer. These inventions involve an oncolytic adenovirus that incorporates a sequence encoding a hyaluronidase enzyme within its genome. This unique design allows the adenovirus to spread more efficiently within the tumor mass, thereby enhancing its oncolytic effect. When injected endovenously, this oncolytic adenovirus leads to significant regressions in tumor volume. Consequently, the adenovirus developed by Guedan Carrió is deemed useful for treating various cancers and pre-malignant states.
Career Highlights
Throughout his career, Sònia Guedan Carrió has worked with esteemed organizations such as the Catalan Institute of Oncology and the Bellvitge Biomedical Research Institute (IDIBELL). His work in these institutions has allowed him to advance his research and contribute to the scientific community's understanding of cancer treatment.
Collaborations
Guedan Carrió has collaborated with notable colleagues, including Manel Maria Cascallo Piqueras and Ramon Alemany Bonastre. These partnerships have further enriched his research endeavors and have played a crucial role in the development of his innovative patents.
Conclusion
Sònia Guedan Carrió is a distinguished inventor whose work on oncolytic adenoviruses represents a significant advancement in cancer treatment. His innovative approach and dedication to research continue to inspire progress in the field of oncology.